Clinical Implications of Expression of EphA2 and PRMT1 in Non-Small Cell Lung Cancer Patients

被引：0

作者：

Zhang, Sheng ^{[1
]}

Qiu, Rui ^{[1
]}

Lv, Zhiping ^{[1
]}

Yang, Liying ^{[1
]}

He, Wei ^{[1
]}

机构：

[1] Ningxia Med Univ, Gen Hosp, Gen Thorac Surg, 804 Shengli St, Yinchuan 750003, Ningxia Hui Aut, Peoples R China

来源：

PAKISTAN JOURNAL OF ZOOLOGY | 2024年 / 56卷 / 03期

关键词：

Key Non-small cell lung cancer; EphA2; PRMT1;

D O I：

10.17582/journal.pjz/20230424070439

中图分类号：

Q95 [动物学];

学科分类号：

071002 ;

摘要：

This study aims to investigate the relationship between EphA2 level and PRMT1 expression in non-small cell lung cancer patients (NSCLCP). This a retrospective observational study totally includes 40 participants, and these participants are divided into following two groups: control group (health participants), experimental group (NSCLCP), and then all these participants receive standardized bronchoalveolar lavage. Participants' general data are collected and analyzed. EphA2 expression and PRMT1 expression in blood samples are determined by ELISA, and EphA2 protein and PRMT1 protein in bronchoalveolar lavage fluid (BALF) samples are determined by western blotting, and then EphA2 mRNA and PRMT1 mRNA in BALF samples are determined by RT-PCR. The EphA2 expression and PRMT1 expression in experimental group were found clearly higher than those in the control. It appears up-regulation of EphA2 and PRMT1 expression can promote the development of NSCLC.

引用

页码：1497 / 1500

页数：4

共 50 条

[31] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
Masago, Katsuhiro
Fujita, Shiro
Hata, Akito
Okuda, Chiyuki
Kaji, Reiko
Katakami, Nobuyuki
Hirata, Yukio
ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
[32] The Expression and Clinical Signification of PD-1 in Lymph Nodes of Patients with Non-small Cell Lung Cancer
Ma, Haitao
Mao, GuoCai
Zhang, GuangBo
Huang, HaiTao
IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (07) : 639 - 646
[33] Immunologic and clinical implications of CD73 expression in non-small cell lung cancer (NSCLC).
Park, Lee Chun
Rhee, Kyunghoon
Kim, Won Bin
Cho, Anderson
Song, Junho
Anker, Jonathan Forrest
Oh, Michael
Bais, Preeti
Namburi, Sandeep
Chuang, Jeffrey
Chae, Young Kwang
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[34] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
Ramírez, JL
Sancho, E
Núñez, L
Sánchez, JJ
Balañá, C
López, P
Martín, C
Monzó, M
Rosell, R
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S39 - S39
[35] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
Pifarre, A
Monzo, M
Martin, C
Sanchez, JJ
Barnadas, A
Rosell, R
ANNALS OF ONCOLOGY, 1998, 9 : 92 - 92
[36] Influence of estrogen in non-small cell lung cancer and its clinical implications
Rodriguez-Lara, Vianey
Hernandez-Martinez, Juan-Manuel
Arrieta, Oscar
JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 482 - +
[37] Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer
Ferrara, Roberto
Auger, Nathalie
Auclin, Edouard
Besse, Benjamin
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 27 - 45
[38] Zyxin expression levels in non-small cell lung cancer patients
Ilic, Dejan
Rancic, Milan
Jevtovic, Tatjana Stoimenov
Petrovic, Veljko
Petrovic, Marina
VOJNOSANITETSKI PREGLED, 2020, 77 (12) : 1309 - 1317
[39] Associations between clinical characteristics and oncogene expression in patients with non-small cell lung cancer
Han, Y.
Yu, D. P.
Zhou, S. J.
Song, X. Y.
Li, Y. S.
Xiao, N.
Liu, Z. D.
Sun, X. J.
Zhao, Q. Y.
Liu, S. K.
GENETICS AND MOLECULAR RESEARCH, 2014, 13 (04) : 8913 - 8924
[40] Expression of VEGFR2 and NRP-1 in non-small cell lung cancer and their clinical significance
Manhua Ding
Liang Liu
Chengxi Hu
Yi Liu
Yun Qiao
Xiaodong Jiang
ChineseJournalofCancerResearch, 2014, 26 (06) : 669 - 677

← 1 2 3 4 5 →